Readiness & Regulatory Gap Assessment
We analyze your current product lines and cleanroom workflows against ISO 13485 and FDA QMSR clauses, identifying critical procedural gaps and mapping out a precise organizational remediation strategy.
At SurkshaNow, we help medical device manufacturers accelerate their quality standards and international market access. By aligning your management workflows and operational processes with the ISO 13485:2016 framework, we ensure your medical equipment, software, and supply chain operations are safe, audit-ready, and fully positioned to win high-stakes healthcare contracts.
Navigating global life-science regulations can be demanding. SurkshaNow simplifies your medical QMS journey's handling everything from initial infrastructure gap analysis to Medical Device File (MDF) development, risk-based process validations, and independent registrar Stage 1 and Stage 2 certification reviews.
Our compliance specialists possess extensive experience across ISO 13485, EU MDR/IVDR, and FDA requirements, ensuring your corporate controls meet strict international expectations.
We build your Quality Management System (QMS) package, prepare Design History Files (DHF), and create reusable process artifacts to eliminate friction during the external assessment phase.
We work directly alongside accredited Certification Bodies to streamline objective evidence collection, management reviews, and pre-audit simulations, accelerating your time-to-certification.
Post-certification, we manage your internal quality review compliance, post-market surveillance (PMS) tracking, and surveillance audit preparation to sustain your compliant status permanently.
Whether you are building an initial manufacturing facility or consolidating multiple standards into an Integrated Management System (IMS), we design a customized remediation roadmap tailored precisely to your production style.
Evaluating organizational frameworks to ensure structural integrity and compliance.
A massive transition occurred when the US FDA officially transitioned to the Quality Management System Regulation (QMSR). The old FDA 21 CFR Part 820 (QSR) has been replaced, and the FDA has formally incorporated ISO 13485:2016 by reference.
This means that if you sell medical devices in the United States, ISO 13485 is no longer just a voluntary global standard—it is now the baseline structural rule for the FDA. SurkshaNow specializes in updating legacy systems to satisfy this unified global inspection criteria.
We guide your organization through a transparent, structured process to achieve and maintain your formal ISO 13485 QMS certification.
We analyze your current product lines and cleanroom workflows against ISO 13485 and FDA QMSR clauses, identifying critical procedural gaps and mapping out a precise organizational remediation strategy.
We author and refine your Medical Device Files (MDF), quality manuals, and comprehensive life-cycle risk management workflows in strict accordance with ISO 14001 / ISO 14971 standards.
Our team manages coordination across engineering and operations, helping you establish cleanroom environmental metrics, execute mandatory employee hygiene training, and build out raw material traceability chains.
We conduct mandatory internal safety audits, facilitate your formal Management Review meetings, and compile the objective software validation and operational logs required before the registrar audit.
We guide you seamlessly through Stage 1 (Documentation Review) and Stage 2 (On-site Implementation Review) audits conducted by your independent, accredited Certification Body.
We help your team manage non-conformances, track customer complaint trend analyses, and establish continuous data monitoring dashboards for hassle-free annual surveillance assessments.
ISO 13485 demands an integrated approach where risk management and process documentation directly influence real-world clinical and patient safety.
|
Core Pillar |
Strategic Objective |
Medical QMS Implementation Profile |
|
Lifecycle Risk Integration |
Embed patient risk reduction into every business process. |
Process frameworks link software development, supplier inputs, and production directly to active ISO 14971 risk control files. |
|
Design Controls & DHF |
Maintain verifiable proof that products match design specifications. |
Systematically logs design inputs, verification protocols, validation matrices, and formal manufacturing design transfers. |
|
Rigid Traceability |
Ensure total line-of-sight tracking for component origins. |
Document structures govern lot numbers, component serialized tracking, software updates, and distribution maps for swift recalls. |
|
Process Validation |
Prove manufacturing setups continuously deliver safe product metrics. |
Mandates specialized software, sterilization, and assembly line validation studies prior to commercial scaling. |
Align your legacy US quality operations with the modern ISO-driven FDA regulatory updates.
Leverage overlap between frameworks to harmonize commercial standard frameworks across non-medical operations.
Build automated, clean compliance frameworks for standalone artificial intelligence and software-driven medical devices.
An ISO 13485 Gap Assessment is a structured pre-certification review designed to evaluate your current business processes, hardware controls, and IT documentation against the standards medical clauses. While not legally mandatory, it significantly enhances your compliance posture by highlighting missing technical controls early—preventing critical audit failures.
The FDA QMSR rule completely discarded the legacy Quality System Regulation (QSR). Instead, the FDA now incorporates ISO 13485:2016 by reference as its baseline requirement for medical device Current Good Manufacturing Practices (CGMP) within the United States.
No. While holding a certificate proves your system aligns with international requirements, the FDA does not issue or fully accept third-party certificates to replace its independent inspections. The FDA layers distinct country-specific criteria (such as unique device identification and mandatory reporting rules) on top of the base audit.
The Medical Device File (MDF) is a comprehensive collection of documents that contains the complete technical specifications, manufacturing requirements, quality metrics, and installation layouts for a specific medical product line, serving as the ultimate operational profile of the device.
The Medical QMS belongs entirely to your business and must be integrated into daily engineering routines by your employees. However, because drafting precise process validations and cleanroom procedures can be highly taxing, companies leverage specialists like SurkshaNow to architect, organize, and write the documentation to clear external evaluations seamlessly.
A comprehensive certification-ready package consists of the main Medical Quality Manual, active Risk Management files (ISO 14971), specific cleanroom sterilization data, internal audit files, past Management Review minutes, and detailed traceability maps.
Yes. ISO 13485 and FDA QMSR strictly mandate that organizations execute separate, independent internal audits at planned intervals. Internal audits provide a qualitative, systematic review of your medical frameworks overall effectiveness and operational legal safety, which raw numbers cannot replicate alone.
While ISO 9001 focuses broadly on general corporate quality and customer satisfaction, ISO 13485 is explicitly tailored for the life sciences. It completely changes the definition of success from customer satisfaction to regulatory safety and lifecycle risk management.
The external audit involves deep structural and operational evaluation. Registrars perform comprehensive document analysis during Stage 1 to verify that your written manuals match the standard. During Stage 2, they execute cleanroom inspections, check sterilization charts, verify testing calibrations, and interview practitioners to confirm those rules are lived out in daily operations.
Timelines vary based on manufacturing complexity. For simple component suppliers, it typically takes 6 to 9 months. For complex, Class III implantable or sterile medical device organizations, engineering remediation, component traceability structures, and process validation runs can stretch timelines to 12 to 18 months.